TrialBMC research notes2014

Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.

Byung-Joon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.